Cytokines derived from these cell types are abundantly expressed, and it is now commonly accepted that tumor necrosis factor (TNF) and interleukin-1 (IL-1) are pivotal mediators in the pathogenesis of RA, providing validated targets for successful therapy [1,2]. Here, TNF is linked to rheumatoid arthritis.